title: The targeting of the sole cyclin D1 is not adequate for mantle cell lymphoma and myeloma therapies.
authors.forename: Guergana
authors.initials: G
authors.lastname: Tchakarska
authors.forename: Anne
authors.initials: A
authors.lastname: Le Lan-Leguen
authors.forename: Lucile
authors.initials: L
authors.lastname: Roth
authors.forename: Brigitte
authors.initials: B
authors.lastname: Sola
mesh_terms: D045744:Cell Line, Tumor; D049109:Cell Proliferation; D019938:Cyclin D1 / Q000235:genetics*; D056742:Cyclin D2 / Q000235:genetics; D016193:G1 Phase; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000235:genetics / Q000473:pathology / Q000628:therapy; D009101:Multiple Myeloma / Q000235:genetics / Q000473:pathology / Q000628:therapy; D034622:RNA Interference; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016196:S Phase
chemical_list: D056742:Cyclin D2; D019938:Cyclin D1
references.citation: Leukemia. 2009 Jan;23(1):10-24
references.pmid: 18843284
references.citation: Mol Cell Biol. 2005 Feb;25(3):1081-8
references.pmid: 15657434
references.citation: Leuk Lymphoma. 2006 Feb;47(2):195-205
references.pmid: 16321849
references.citation: J Immunol. 2004 Sep 1;173(5):2901-7
references.pmid: 15322145
references.citation: J Clin Invest. 2008 May;118(5):1750-64
references.pmid: 18431519
references.citation: Leukemia. 2008 Nov;22(11):2097-105
references.pmid: 18685613